Learn how to build decision-grade disease registries that turn real-world data into reliable evidence for regulatory, clinical, and market-access decisions.
- Inside A Sponsor-Site Relationship That Actually Worked
- Real-World Data Won't Replace Trials. Here's Its Real Job
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
- What Ecological Momentary Assessment Taught Us About Real-World Hearing Outcomes
- AI Governance Is Becoming A Competitive Edge In Trials
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?
- From 73% Noncompliant To 2.4%: Building A Compliance Office
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
IRT vs. RTSM: What Sponsors Need To Know When Choosing Clinical Trial Technology
Mastering the nuances between IRT and RTSM allows trial teams to move past confusing jargon and focus on the supply intelligence and randomization logic essential for study integrity.
-
Reducing Risks And Accelerating Study Startup Through An eCOA Library
Find out how the shift towards a more patient-centric drug development landscape has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool to gather patient experience data in most trials today.
-
How Digital Therapeutics Tools Interact To Improve Patient Care
This comprehensive overview illustrates the intersection between prescription digital therapeutics, digital health tools, and decentralized clinical trials in a remote care setting.
-
The Site's Guide To Recovering Clinical Technology Costs From Sponsors
Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.
-
Digital Health's Role In Improving Patient Engagement
Digital health is proving to be much more than just a trendy fad—it’s a movement that is here to stay. So how can digital health improve patient engagement, and why is it important?
-
Quality By Design: How eCOA Improves Data Oversight And Quality
Unearth the innovative ways electronic clinical outcome assessments (eCOA) are improving data accuracy, reducing errors, and ensuring robust oversight in clinical trials.
-
The Strategic Case For RTSM in Phase 1 Trials
Phase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.
-
Strategies For More Accurate Clinical Trial Forecasting And Budgeting
Explore some of the best strategies and practices to ensure clinical trial staff get approval for their budgets, with forecasts as accurate as possible.
-
Electronic Trial Master File: The Metrics
Here, the author defines several key ideas surrounding data, reports, and insights, honing in on one that is uniquely electronic and only possible because of the move to eTMF — Metrics!
-
Reduce The Need To Perform A 12-Lead ECG In Resource Limited Settings
Remote cardiac monitoring technology is enabling the pharmaceutical industry to shift towards innovative, efficient, and patient-friendly clinical trials.
RECENT NEWSLETTERS
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps